An Open Label, Proof of Principle Study to Evaluate the Efficacy and Safety of Solithromycin for the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2017
At a glance
- Drugs Solithromycin (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Proof of concept; Therapeutic Use
- Sponsors Cempra Pharmaceuticals
- 17 Mar 2017 Status changed from active, no longer recruiting to completed.
- 17 Feb 2017 Status changed from recruiting to active, no longer recruiting.
- 29 Sep 2016 According to a Cempra Pharmaceuticals media release, the company will host webcast and conference call with principal investigator to discuss interim results.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History